CA9 expression is suggested to be a strong predictor of recurrence, progression, and overall survival of bladder cancer patients because it was expressed differentially in noninvasive versus invasive tumors, in low-grade versus high-grade bladder cancer, and in primary tumors versus metastases [16]. The gene discussed is CA9; the disease is urinary bladder carcinoma.